Tag:

China

Latest Headlines

Latest Headlines

Feds eyed GlaxoSmithKline's Chinese consumer biz for bribery, too

GlaxoSmithKline may have a bigger problem in China than previously thought. Before news about potential corruption in its pharma business surfaced, U.S. officials were already looking into possible bribery in its consumer healthcare unit. And so was GSK.

China sweeps up gang that made and sold 90M toxic capsules

China has interrupted another group it says was illegally manufacturing capsules from chromium-laced gelatin. A lot of them.

China's new biotech billionaire beefs up cardio pipeline with $600M buyout

Newly minted biopharma billionaire Liu Dianbo has added to his fortune while burnishing his rep as one of the top biotech drug developers in China. His company, Luye Pharma Group, acquired a 58% stake in Beijing Jialin Pharma Pharmaceutical for close to $600 million, beefing up its pipeline of cardiovascular drugs while expanding its product lineup.

China's Luye Pharma founder soars into pharma's billionaire echelon

China's pharma corruption crackdown hasn't helped multinationals' top lines, which only recently began returning to normal after taking a hit last fall. But it may be opening up an opportunity for domestic drugmakers and their owners--like new Billionaire Club member Liu Dian Bo--to make a splash.

Medtronic stumbles in India, China but holds up in U.S.

Medtronic has tied its long-term growth to three pillars: strong U.S. sales, double-digit growth in emerging markets and Covidien. But last quarter, the medical device giant didn't deliver on emerging market revenue growth as it encountered difficulties with distributors in India and China. It expects to return to double-digit gains in both countries this fiscal year.

China's top health authority calls for more homegrown med tech

Global med tech companies could soon face mounting competition in China, as the country's top health authority is calling for a new set of initiatives to promote homegrown products and jumpstart the domestic industry.

Private hospitals in China are a priority for med tech Mindray

Chinese medical device maker Mindray is seeing slower sales at home but hopes a focus on private hospitals in China will help turn that around. The company reduced its 2014 guidance, but investors were forgiving and pushed shares up 3% in early trading on second-quarter earnings.

UPDATED: GSK's private eye sentenced to 2.5 years in Chinese prison

China finally has a verdict on the husband-wife investigator team linked to GlaxoSmithKline's bribery scandal: U.K. citizen Peter Humphrey is headed for 2.5 years behind bars, and his American wife, Yu Yingzeng, will get 2 years, Pharmafile reports.

Quintiles and Roche take to China with testing partnership

Quintiles has signed a deal with a Roche diagnostics subsidiary to offer cancer screenings in China, looking to capitalize on the growing market for clinical trials in the country.

Roche, Quintiles partner for companion diagnostics in China

Ventana and Quintiles are partnering up to provide companion diagnostic testing services in China for early clinical trials. China is among a few countries that requires patient samples used in clinical trials to be tested domestically for inclusion in the country's approval process.